CDNA
CareDx, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 24 ▲ CareDx reported strong Q4 and full-year 2025 financial results with…
- Feb 25 ▲ CareDx reported strong 2025 financial results with 14% year-over-yea…
- Apr 16 ▲ CareDx is divesting its lab products business to Eurobio Scientific…
- Jun 15 ▼ 2 insiders sell $704.6K at $23.66
- Jun 26 to Jun 29 ▼ 2 days of insider sells: $1.2M by 1 insider, avg $29.24
- Jul 16 ▼ 2 insiders sell $5.5M at $37.46
- Aug 4 to Aug 5 ▼ 2 days of insider sells: $3.9M by 4 insiders, avg $46.82
- Sep 2 Canaccord Genuity initiates
- Oct 29 ▲ Earnings: CDNA Q3 2026 Earnings: EPS $0.7 (+178.4% vs est)
- Oct 29 ▲ CareDx reported Q3 2026 revenue of $139M (up 39% YoY, above the $122…
- Nov 5 to Nov 10 ▼ 2 days of insider sells: $5.2M by 2 insiders, avg $78.02
- Nov 11 Piper Sandler initiates
Signal stack
Where each data set points today.
- InsidersBEARISH
7 insiders sold $16.4M.
- InstitutionsMIXED
Q3 2026: 35 added (2 new), 26 trimmed or exited. Largest new: Empowered Funds $15.4M.
- AnalystsBULLISH
10 of 13 rate it Buy or better. Every target is above the price.
- Short sellersSTEADY
Short interest +7.0% to 7.19M shares. 5.3 days to cover, ≈13.7% of shares.
- TrendUPTREND
10% above its 50-day average.
- SocialQUIET
Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup is alerting.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | $133.9M |
| FRANKLIN TEMPLETON INC | DOUBLED | $84.6M |
| Qube Research & Technologies Ltd | ADD | $42.7M |
| Sumitomo Mitsui Trust Group, Inc. | TRIM | $40.8M |
| Nuveen, LLC | DOUBLED | $33.6M |
| MORGAN STANLEY | TRIM | $28.9M |
| Boston Partners | NEAR_EXIT | $24.8M |
| Russell Investments Group, Ltd. | TRIM | $18.8M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
13 analystsPrice is below the lowest target. Median implies +25%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 11, 2026 | Piper Sandler INITIATE | Overweight |
| Oct 30, 2026 | BTIG MAINTAIN | Buy |
| Oct 27, 2026 | BTIG MAINTAIN | Buy |
| Oct 19, 2026 | Canaccord Genuity MAINTAIN | Buy |
| Sep 24, 2026 | BTIG MAINTAIN | Buy |
| Sep 2, 2026 | Canaccord Genuity INITIATE | Buy |
Washington
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Bickerstaff George Director Nov 10, 2026 | EXERCISE | $221.1K |
Novack Jeffrey Adam Secretary and General Counsel Nov 10, 2026 | SELL | $75.0K |
Novack Jeffrey Adam Secretary and General Counsel Nov 10, 2026 | SELL | $241.1K |
Novack Jeffrey Adam Secretary and General Counsel Nov 10, 2026 | SELL | $16.2K |
Novack Jeffrey Adam Secretary and General Counsel Nov 6, 2026 | TAX W/H | $118.2K |
Kennedy Keith CFO & COO Nov 5, 2026 | EXERCISE | $1.5M |
Kennedy Keith CFO & COO Nov 5, 2026 | SELL | $2.2M |
Kennedy Keith CFO & COO Nov 5, 2026 | SELL | $958.4K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
16 filings · 4 bullish · 1 bearish · 11 neutral- NEUTRAL CLUSTERNov 12, 2026
Two CareDx insiders, including the CFO/COO and General Counsel, sold a combined $2.40M in…
The sales are small relative to market cap and executed under 10b5-1 plans, suggesting routine portfolio diversification rather than a negative signal. Monitor for any upcoming earnings or material…
- NEUTRAL 144Nov 12, 2026
Michael Goldberg, a director of CareDx, filed a Form 144 notice of intent to sell 13,800 shares of…
Director's Form 144 is a routine notice of intent to sell vested equity. The sale amount is immaterial relative to market cap. Monitor for actual execution on Form 4, but no immediate read-through…
- NEUTRAL 144Nov 10, 2026
Jeffrey Novack, an officer of CareDx, filed a Form 144 notice of intent to sell 4,096 shares of…
This is a routine Form 144 filing following RSU vesting. The sale amount is small relative to the company's market cap and the insider's likely total holdings. Monitor for any subsequent Form 4…
- NEUTRAL SC 13GNov 10, 2026
State Street Corp filed a new Schedule 13G disclosing a 5.1% passive stake in CareDx as of…
State Street's 5.1% passive stake is consistent with index fund and institutional ownership patterns. The filing confirms continued institutional interest following CareDx's strong Q3 earnings and…
All CDNA filing & press-release reports (16)
- CLUSTER reportNov 12, 2026
- 144 reportNov 12, 2026
- 144 reportNov 10, 2026
- SC 13G reportNov 10, 2026
- 144 reportNov 5, 2026
- 8-K reportOct 29, 2026
- INST-CLUSTER reportOct 29, 2026
- CLUSTER reportAug 6, 2026
- 144 reportAug 4, 2026
- CLUSTER reportJul 17, 2026
- CLUSTER reportJun 16, 2026
- DEFA14A reportJun 5, 2026
- S-3ASR reportApr 28, 2026
- 8-K reportApr 16, 2026
- 8-K/A reportFeb 25, 2026
- 8-K reportFeb 24, 2026